Secure shopping
Healthcare and pharma
The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
India’s pharmaceuticals and healthcare sector has a global reputation. India accounts for approximately 20% of the worldwide market share of generic drugs, making it the leading exporter, particularly to the developing world. India is ...
View more details
Thailand’s pharmaceuticals and healthcare sector has developed considerably over the past few decades. The Thai government initiated its plan to deliver universal healthcare to all Thais in 2002, which has proven so successful that more than 99 ...
View more details
Malaysia has a highly developed pharmaceuticals and healthcare sector. Malaysia’s healthcare system is two-tiered. The Ministry of Health (“MoH”) provides comprehensive, taxpayer-funded healthcare services for Malaysian ...
View more details
In Q3 2021, Chinese residents’ expenditures on medicine and medical services continued to increase. Per capita spending of urban residents reached RMB 635, up by 10.8% y/y, and that of rural residents recorded a growth of 9 ...
View more details
As the global epidemic is being contained and China’s economic growth has returned to normal, the growth of the country's healthcare sector is likely to gradually slow down to pre-pandemic levels. In the second quarter of 2021, the ...
View more details
India’s pharmaceuticals and healthcare sector has been dominated by a second wave of COVID-19 infections beginning in April 2021 driven by the Delta variant. The surge caught the Indian government and the pharmaceuticals and ...
View more details
China's healthcare system is hospital-centric, and most of the inpatient and outpatient care in the country is delivered in public hospitals and basic medical institutions. However, due to the growing demand ...
View more details
Since China initiated 5G technology R&D and standard formulation in 2013, the landmark national-level policy has been Made in China 2025 issued by the State Council in 2015. 5G technology, along with integrated circuits ...
View more details